ALNY vs TMP · P/E 76, rev $2.25B vs P/E 7.5, rev $79.3M
Alnylam Pharmaceuticals Inc (ALNY) versus Tompkins Financial Corporation (TMP) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Tompkins Financial Corporation (TMP) is a banks - regional company listed on AMEX.
Latest reported ALNY revenue for 2024-12-31 was $2.25B. Net income was -$278.2M. Revenue was up 23.0% from 2023-12-31 to 2024-12-31. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported TMP revenue for 2024-12-31 was $79.3M. Net income was $71.0M. Revenue was up 5.7% from 2023-12-31 to 2024-12-31. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
Not investment advice. Open the ALNY and TMP stock pages for the full models.
Not investment advice.